On March 25, 2009 the MLSC Board of Directors approved a $9.5 million grant to support completion of the New England Regional Biosafety Laboratory at Tufts University’s Cummings School of Veterinary Medicine in Grafton.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
